Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome. Benzinga · Sep 27, 2022
Stocks That Hit 52-Week Lows On Friday During Friday's session, 61 companies made new 52-week lows. Benzinga · Jul 22, 2022
Kiora Commences Mid-Stage Rare Eye Disease Study Kiora Pharmaceuticals (NASDAQ: KPRX) enrols the first patient as a part of a Phase 2 study evaluating KIO-201 topical eye drops in patients with Persistent Corneal Epithelial Defect (PCED). Benzinga · Jul 5, 2022
12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million. Benzinga · Jun 9, 2022